MedTrace Logo

Arrhythmia Prediction Trial

NCT02175836 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-01-28

No results posted yet for this study

Summary

Patients with Ischaemic and Dilated Cardiomyopathy, face an increased risk for Arrhythmic Sudden Cardiac Death. The purpose of this study is to estimate the performance of Modern Non-Invasive Indices and the performance of Programmed Ventricular Stimulation in Sudden Cardiac Death Prediction.

Conditions

Sponsors & Collaborators

  • University of Athens

    lead OTHER

Principal Investigators

  • Petros Arsenos, MD, PhD · First Department of Cardiology, Medical School, National & Kapodistrian University of Athens, Greece

Eligibility

Min Age
20 Years
Max Age
82 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02175836 on ClinicalTrials.gov